Episode 142 - Continuing vs. Withholding RAS inhibitors before Surgery
Update: 2025-11-13
Description
Welcome back Rounds Table Listeners! Today we have a solo episode with Dr. Mike Fralick. This week, he discusses a recent systematic review and meta-analysis that looks at continuing versus withholding RAS inhibitors before noncardiac surgery. Here we go!
- Evaluating the risks and benefits of continuing versus withholding renin–angiotensin system inhibitors: a systematic review and meta-analysis with trial sequential analysis (0:00 – 8:20 ).
The Good Stuff (8:21 – 9:44 ):
Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
